JAMP ELAGOLIX DIN 02571056
Status: Approved
Holder: JAMP PHARMA CORPORATION
Health Canada record
| Active ingredient(s) | ELAGOLIX (ELAGOLIX SODIUM) 200 MG |
|---|
| Dosage form | Tablet |
|---|
| Route | Oral |
|---|
| Schedule | PRESCRIPTION |
|---|
| Class | Human |
|---|
| ATC | H01CC03 ELAGOLIX |
|---|
| Original market date | |
|---|
| Current status date | 06-Oct-2026 |
|---|
| Source | Health Canada DPD |
|---|
Establishment licence of the holder
Jamp Pharma Corporation — licence 100590, currently licensed, last inspection rating I (2026-09-16).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing ELAGOLIX (ELAGOLIX SODIUM)
| DIN | Product | Company | Form | Strength | Status |
|---|
| 02571048 | JAMP ELAGOLIX | JAMP PHARMA CORPORATION | Tablet | ELAGOLIX (ELAGOLIX SODIUM) 150 MG | Approved |
| 02481332 | ORILISSA | ABBVIE CORPORATION | Tablet | ELAGOLIX (ELAGOLIX SODIUM) 150 MG | Marketed |
| 02481340 | ORILISSA | ABBVIE CORPORATION | Tablet | ELAGOLIX (ELAGOLIX SODIUM) 200 MG | Marketed |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|
| 38410 | 2026-10-06 | Abbreviated New Drug Submission (ANDS) | |
Request a quote for JAMP ELAGOLIX
How to read a Canadian DIN record